| P50 | author | Anne-Marie Mes-Masson | Q30002003 |
| | Réjean Lapointe | Q30002007 |
| | Benjamin Péant | Q59660678 |
| | Fred Saad | Q88065306 |
| P2093 | author name string | Jessica Godin-Ethier | |
| | Nathalie Delvoye | |
| | Mona Alam Fahmy | |
| | Meghan Aversa | |
| | Philippe O Gannon | |
| | Matthew Hassler | |
| | Alexis O Poisson | |
| P2860 | cites work | Cancer statistics, 2008 | Q27860585 |
| | A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 |
| | Regulation of immune responses by L-arginine metabolism | Q29614284 |
| | T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer | Q33952036 |
| | Developmental and hormonal regulation of the Xenopus liver-type arginase gene | Q34322852 |
| | The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis | Q34411509 |
| | Presence of prostate cancer metastasis correlates with lower lymph node reactivity | Q58325220 |
| | Expression and Nuclear Localization of ErbB3 in Prostate Cancer | Q58325229 |
| | Arginine and ornithine metabolizing enzymes in testosterone-induced hypertrophic mouse kidney | Q72312101 |
| | Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma | Q72697573 |
| | Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells | Q73053388 |
| | Possible implications of arginase and diamine oxidase in prostatic carcinoma | Q73675931 |
| | A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells | Q80589298 |
| | Androgen receptor signaling in androgen-refractory prostate cancer | Q34444942 |
| | Tumor escape mechanisms in prostate cancer | Q36345907 |
| | Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. | Q36403503 |
| | Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients | Q36614450 |
| | Pathological changes in prostate lesions after androgen manipulation | Q37215920 |
| | The role of systemic cytotoxic therapy for prostate cancer | Q37336882 |
| | Arginase: an emerging key player in the mammalian immune system | Q37395887 |
| | Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients. | Q38421050 |
| | Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. | Q39771475 |
| | Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors. | Q39926659 |
| | Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma | Q39935779 |
| | Disruption of arginase II alters prostate tumor formation in TRAMP mice | Q39956306 |
| | Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation | Q39980991 |
| | Expression of arginase II in prostate cancer | Q40023751 |
| | NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model | Q40041156 |
| | Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer | Q40105462 |
| | NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells | Q40172516 |
| | Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-kappaB activation in prostate cancer cells. | Q40397903 |
| | Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer | Q40414396 |
| | Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells | Q40871819 |
| | Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells | Q40928270 |
| | NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. | Q41005555 |
| | Enzyme activities in prostatic carcinoma related to Gleason grades | Q41393404 |
| | Ebp1 expression in benign and malignant prostate | Q43212302 |
| | Regulation of arginase II by interferon regulatory factor 3 and the involvement of polyamines in the antiviral response | Q44440839 |
| | Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells | Q44851111 |
| | Testosterone down-regulates ornithine aminotransferase gene and up-regulates arginase II and ornithine decarboxylase genes for polyamines synthesis in the murine kidney | Q45147941 |
| | High-performance liquid chromatographic assay for the quantitation of L-arginine in human plasma | Q46540801 |
| | Effects of testosterone and prolactin on rat prostatic weight, 5alpha-reductase, and arginase | Q47346124 |
| | Arginine catabolism in Aspergillus nidulans is regulated by the rrmA gene coding for the RNA-binding protein | Q48078023 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| | interleukins | Q194908 |
| P304 | page(s) | e12107 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer | |
| P478 | volume | 5 | |